“Two-phase”的搜索结果，显示 181-190 项，共有 4521 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Jacksonville, Fla., Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety ... 2, a protein needed for cancer cell survival. Giving venetoclax ... A Study to Test the Effectiveness of Two ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Jacksonville, Fla., Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety ... 2, a protein needed for cancer cell survival. Giving venetoclax ... A Study to Test the Effectiveness of Two ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 dose (RP2D) and schedule of KTX-1001 ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety ... 2, a protein needed for cancer cell survival. Giving venetoclax ... A Study to Test the Effectiveness of Two ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This phase I trial evaluates the safety ... 2, a protein needed for cancer cell survival. Giving venetoclax ... A Study to Test the Effectiveness of Two ...